State Street’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $266M | Buy |
2,884,620
+88,893
| +3% | +$8.92M | 0.01% | 810 |
|
|
2025
Q4 | $286M | Buy |
2,795,727
+7,950
| +0.3% | +$711K | 0.01% | 767 |
|
|
2025
Q3 | $174M | Sell |
2,787,777
-51,888
| -2% | -$2.82M | 0.01% | 1021 |
|
|
2025
Q2 | $148M | Buy |
2,839,665
+39,626
| +1% | +$1.77M | 0.01% | 1092 |
|
|
2025
Q1 | $119M | Sell |
2,800,039
-49,074
| -2% | -$2.12M | ﹤0.01% | 1180 |
|
|
2024
Q4 | $87M | Buy |
2,849,113
+54,738
| +2% | +$1.54M | ﹤0.01% | 1424 |
|
|
2024
Q3 | $64.1M | Buy |
2,794,375
+39,398
| +1% | +$1.12M | ﹤0.01% | 1577 |
|
|
2024
Q2 | $79.6M | Buy |
2,754,977
+126,940
| +5% | +$2.96M | ﹤0.01% | 1410 |
|
|
2024
Q1 | $54.2M | Buy |
2,628,037
+55,713
| +2% | +$1.19M | ﹤0.01% | 1683 |
|
|
2023
Q4 | $69.6M | Buy |
2,572,324
+155,177
| +6% | +$4.07M | ﹤0.01% | 1515 |
|
|
2023
Q3 | $71.6M | Buy |
2,417,147
+67,890
| +3% | +$2.39M | ﹤0.01% | 1403 |
|
|
2023
Q2 | $84.1M | Buy |
2,349,257
+775,806
| +49% | +$22.3M | ﹤0.01% | 1337 |
|
|
2023
Q1 | $36.9M | Buy |
1,573,451
+85,956
| +6% | +$2.46M | ﹤0.01% | 1843 |
|
|
2022
Q4 | $40.5M | Sell |
1,487,495
-16,494
| -1% | -$755K | ﹤0.01% | 1779 |
|
|
2022
Q3 | $81M | Buy |
1,503,989
+44,483
| +3% | +$2.28M | 0.01% | 1252 |
|
|
2022
Q2 | $58.9M | Buy |
1,459,506
+70,336
| +5% | +$3.49M | ﹤0.01% | 1519 |
|
|
2022
Q1 | $92M | Buy |
1,389,170
+58,867
| +4% | +$4.03M | ﹤0.01% | 1348 |
|
|
2021
Q4 | $133M | Buy |
1,330,303
+18,417
| +1% | +$1.9M | 0.01% | 1085 |
|
|
2021
Q3 | $164M | Buy |
1,311,886
+48,365
| +4% | +$5.75M | 0.01% | 946 |
|
|
2021
Q2 | $157M | Buy |
1,263,521
+269,276
| +27% | +$36.2M | 0.01% | 994 |
|
|
2021
Q1 | $152M | Buy |
994,245
+10,062
| +1% | +$1.52M | 0.01% | 931 |
|
|
2020
Q4 | $127M | Buy |
984,183
+114,552
| +13% | +$13.2M | 0.01% | 972 |
|
|
2020
Q3 | $97.2M | Buy |
869,631
+36,587
| +4% | +$3.35M | 0.01% | 990 |
|
|
2020
Q2 | $67.6M | Buy |
833,044
+333,792
| +67% | +$26.9M | ﹤0.01% | 1239 |
|
|
2020
Q1 | $34.7M | Sell |
499,252
-24,156
| -5% | -$1.85M | ﹤0.01% | 1494 |
|
|
2019
Q4 | $40.9M | Buy |
523,408
+20,923
| +4% | +$1.51M | ﹤0.01% | 1649 |
|
|
2019
Q3 | $32.1M | Buy |
502,485
+60,666
| +14% | +$5.34M | ﹤0.01% | 1741 |
|
|
2019
Q2 | $38.1M | Buy |
441,819
+152,043
| +52% | +$11.6M | ﹤0.01% | 1659 |
|
|
2019
Q1 | $22.2M | Buy |
289,776
+67,990
| +31% | +$3.77M | ﹤0.01% | 1967 |
|
|
2018
Q4 | $8.34M | Buy |
+221,786
| New | +$8.17M | ﹤0.01% | 2510 |
|
Other funds holding GH
VPM
VCM
State Street's GH Position: Q1 2026 in Review
State Street increased its Guardant Health (GH) stake by 3.2% in Q1 2026, buying an estimated $8.92M and bringing the position to 2,884,620 shares worth $266M. The position accounts for 0.01% of the portfolio, ranked #810.
State Street first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $286M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- State Street held 2,884,620 shares of Guardant Health worth $266M as of Q1 2026.
- State Street bought 88,893 Guardant Health shares in Q1 2026, an estimated $8.92M.
- Guardant Health made up 0.01% of State Street's portfolio in Q1 2026, its #810 holding.
- State Street first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
- State Street's Guardant Health position peaked at $286M in Q4 2025.
- 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.